Indoco Remedies informs about press release

30 Jan 2026 Evaluate
Indoco Remedies has announced the final approval of the Company’s Abbreviated New Drug Application (ANDA) for Lacosamide Oral Solution USP, 10 mg/mL, to market a generic equivalent to the reference listed drug (RLD), Vimpat Oral Solution, 10 mg/mL, of UCB, Inc. (UCB), from USFDA. This may kindly be considered as a disclosure pursuant to Regulation 30 of the SEBI Listing Regulations. It has enclosed press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

198.50 1.20 (0.61%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×